CID 130412842

Befotertinib

Structural Information

Molecular Formula
C29H32F3N7O2
SMILES
CN(C)CCN(C)C1=CC(=C(C=C1NC(=O)C=C)NC2=NC=CC(=N2)C3=CN(C4=CC=CC=C43)CC(F)(F)F)OC
InChI
InChI=1S/C29H32F3N7O2/c1-6-27(40)34-22-15-23(26(41-5)16-25(22)38(4)14-13-37(2)3)36-28-33-12-11-21(35-28)20-17-39(18-29(30,31)32)24-10-8-7-9-19(20)24/h6-12,15-17H,1,13-14,18H2,2-5H3,(H,34,40)(H,33,35,36)
InChIKey
USOCZVZOXKTJTI-UHFFFAOYSA-N
Compound name
N-[2-[2-(dimethylamino)ethyl-methylamino]-4-methoxy-5-[[4-[1-(2,2,2-trifluoroethyl)indol-3-yl]pyrimidin-2-yl]amino]phenyl]prop-2-enamide
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

1
References

81
Patents

567.25696 Da
Monoisotopic Mass

4.8
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 568.26424 226.3
[M+Na]+ 590.24618 233.9
[M+NH4]+ 585.29078 227.6
[M+K]+ 606.22012 230.6
[M-H]- 566.24968 227.2
[M+Na-2H]- 588.23163 231.0
[M]+ 567.25641 227.1
[M]- 567.25751 227.1
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe